menu Search
Calta

Calta

potassium citrate

Manufacturer:

Cooper Pharma

Distributor:

Cathay YSS
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
K citrate
Indications/Uses
Management of renal tubular acidosis w/ Ca stones, hypocitraturic Ca oxalate nephrolithiasis of any etiology, & uric acid lithiasis w/ or w/o Ca stones.
Click to view Calta detailed prescribing information
Dosage/Direction for Use
Severe hypocitraturia (urinary citrate <150 mg/day) 20 mEq tid or 15 mEq qid (60 mEq/day). Mild to moderate hypocitraturia (>150 mg/day) 10 mEq tid (30 mEq/day).
Click to view Calta detailed prescribing information
Overdosage
View Calta overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food: Take w/ meals or w/in 30 min after meals/bedtime snack. Swallow whole, do not crush/chew/suck tab.
Contraindications
Patients w/ hyperkalemia or who have conditions predisposing to hyperkalemia eg, chronic renal failure, uncontrolled DM, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown, or the administration of K-sparing agent (eg, triamterene, spironolactone or amiloride). Patients suffering from delayed gastric emptying, esophageal compression, intestinal obstruction or stricture or those taking anticholinergic medication. Not to be given to patients w/ PUD. Renal insufficiency (GFR <0.7 mL/kg/min).
Click to view Calta detailed prescribing information
Special Precautions
May produce hyperkalemia & cardiac arrest in patients w/ impaired mechanisms for excreting K. Avoid use in patients w/ chronic renal failure, or any other condition which impairs K excretion eg, severe myocardial damage or heart failure. Discontinue immediately & investigate the possibility of bowel perforation or obstruction if there is severe vomiting, abdominal pain or GI bleeding. Perform 24-hr urinary citrate &/or urinary pH measurements every 4 mth to determine adequacy of initial dosage & evaluate effectiveness of any dosage change. Should be given to pregnant & breastfeeding women only if clearly needed. 1,080 mg: Safety & effectiveness in childn have not been established.
Click to view Calta detailed prescribing information
Use In Pregnancy & Lactation
Click to view Calta detailed prescribing information
Adverse Reactions
Abdominal discomfort, vomiting, diarrhea, loose bowel movements or nausea.
Click to view Calta detailed prescribing information
Drug Interactions
Concomitant administration w/ K-sparing diuretic (eg, triamterene, spironolactone or amiloride).
Click to view Calta detailed prescribing information
Storage
View Calta storage conditions for details to ensure optimal shelf-life.
Description
View Calta description for details of the chemical structure and excipients (inactive components).
Action
View Calta mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Other Drugs Acting on the Genito-Urinary System
ATC Classification
A12BA02 - potassium citrate ; Belongs to the class of potassium-containing preparations. Used as dietary supplements.
Regulatory Classification
Rx
Presentation/Packing
Form
Calta ER tab 1,080 mg
Packing/Price
30's (P412.5/box)
Form
Calta ER tab 1.620 g (15 mEq)
Packing/Price
30's (P705/box)